INSPIRE MEDICAL SYSTEMS INC (INSP) Stock Fundamental Analysis
NYSE:INSP • US4577301090
59.53 USD
-0.25 (-0.42%)
At close: Feb 20, 2026
59.53 USD
0 (0%)
After Hours: 2/20/2026, 8:04:00 PM
Taking everything into account, INSP scores 6 out of 10 in our fundamental rating. INSP was compared to 185 industry peers in the Health Care Equipment & Supplies industry. INSP has an excellent financial health rating, but there are some minor concerns on its profitability. INSP has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
- In the past year INSP was profitable.
- In the past year INSP had a positive cash flow from operations.
- The reported net income has been mixed in the past 5 years: INSP reported negative net income in multiple years.
- In multiple years INSP reported negative operating cash flow during the last 5 years.
1.2 Ratios
- INSP has a better Return On Assets (5.52%) than 82.70% of its industry peers.
- With a decent Return On Equity value of 6.69%, INSP is doing good in the industry, outperforming 80.00% of the companies in the same industry.
- INSP has a better Return On Invested Capital (4.82%) than 74.59% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.52% | ||
| ROE | 6.69% | ||
| ROIC | 4.82% |
ROA(3y)6.51%
ROA(5y)-0.53%
ROE(3y)7.56%
ROE(5y)-0.94%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- INSP has a Profit Margin of 5.05%. This is in the better half of the industry: INSP outperforms 77.84% of its industry peers.
- INSP has a Operating Margin of 4.16%. This is in the better half of the industry: INSP outperforms 68.11% of its industry peers.
- Looking at the Gross Margin, with a value of 84.92%, INSP belongs to the top of the industry, outperforming 94.59% of the companies in the same industry.
- In the last couple of years the Gross Margin of INSP has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.16% | ||
| PM (TTM) | 5.05% | ||
| GM | 84.92% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.64%
GM growth 5Y0.15%
2. Health
2.1 Basic Checks
- INSP has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- Compared to 1 year ago, INSP has less shares outstanding
- The number of shares outstanding for INSP has been increased compared to 5 years ago.
- INSP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- An Altman-Z score of 8.81 indicates that INSP is not in any danger for bankruptcy at the moment.
- INSP has a Altman-Z score of 8.81. This is amongst the best in the industry. INSP outperforms 87.57% of its industry peers.
- INSP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 8.81 |
ROIC/WACC0.48
WACC10.02%
2.3 Liquidity
- A Current Ratio of 5.29 indicates that INSP has no problem at all paying its short term obligations.
- INSP has a better Current ratio (5.29) than 80.54% of its industry peers.
- INSP has a Quick Ratio of 4.01. This indicates that INSP is financially healthy and has no problem in meeting its short term obligations.
- With a decent Quick ratio value of 4.01, INSP is doing good in the industry, outperforming 75.68% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.29 | ||
| Quick Ratio | 4.01 |
3. Growth
3.1 Past
- INSP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 45.09%, which is quite impressive.
- Looking at the last year, INSP shows a quite strong growth in Revenue. The Revenue has grown by 13.60% in the last year.
- Measured over the past years, INSP shows a very strong growth in Revenue. The Revenue has been growing by 51.20% on average per year.
EPS 1Y (TTM)45.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%40.87%
Revenue 1Y (TTM)13.6%
Revenue growth 3Y30.76%
Revenue growth 5Y51.2%
Sales Q2Q%12.25%
3.2 Future
- Based on estimates for the next years, INSP will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.46% on average per year.
- INSP is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.27% yearly.
EPS Next Y-29.76%
EPS Next 2Y1.11%
EPS Next 3Y11.77%
EPS Next 5Y14.46%
Revenue Next Year7.01%
Revenue Next 2Y8.03%
Revenue Next 3Y9.22%
Revenue Next 5Y10.27%
3.3 Evolution
- Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 23.72, INSP is valued on the expensive side.
- Compared to the rest of the industry, the Price/Earnings ratio of INSP indicates a somewhat cheap valuation: INSP is cheaper than 80.00% of the companies listed in the same industry.
- The average S&P500 Price/Earnings ratio is at 26.99. INSP is around the same levels.
- With a Price/Forward Earnings ratio of 33.77, INSP can be considered very expensive at the moment.
- INSP's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. INSP is cheaper than 69.73% of the companies in the same industry.
- When comparing the Price/Forward Earnings ratio of INSP to the average of the S&P500 Index (28.06), we can say INSP is valued slightly more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 23.72 | ||
| Fwd PE | 33.77 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of INSP indicates a somewhat cheap valuation: INSP is cheaper than 71.89% of the companies listed in the same industry.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of INSP indicates a rather cheap valuation: INSP is cheaper than 93.51% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 17.51 | ||
| EV/EBITDA | 24.27 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y1.11%
EPS Next 3Y11.77%
5. Dividend
5.1 Amount
- INSP does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
59.53
-0.25 (-0.42%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-11 2026-02-11/amc
Earnings (Next)05-04 2026-05-04/amc
Inst Owners111.59%
Inst Owner Change9.03%
Ins Owners0.74%
Ins Owner Change-0.28%
Market Cap1.73B
Revenue(TTM)911.98M
Net Income(TTM)44.56M
Analysts76.8
Price Target131.09 (120.21%)
Short Float %13.43%
Short Ratio2.4
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)193.12%
Min EPS beat(2)114.53%
Max EPS beat(2)271.71%
EPS beat(4)4
Avg EPS beat(4)144.95%
Min EPS beat(4)54.07%
Max EPS beat(4)271.71%
EPS beat(8)8
Avg EPS beat(8)284.67%
EPS beat(12)12
Avg EPS beat(12)208.03%
EPS beat(16)16
Avg EPS beat(16)165.01%
Revenue beat(2)0
Avg Revenue beat(2)-0.43%
Min Revenue beat(2)-0.69%
Max Revenue beat(2)-0.17%
Revenue beat(4)1
Avg Revenue beat(4)-0.14%
Min Revenue beat(4)-0.84%
Max Revenue beat(4)1.13%
Revenue beat(8)4
Avg Revenue beat(8)0.25%
Revenue beat(12)7
Avg Revenue beat(12)1.47%
Revenue beat(16)11
Avg Revenue beat(16)3.25%
PT rev (1m)-8.19%
PT rev (3m)15%
EPS NQ rev (1m)0.74%
EPS NQ rev (3m)30.36%
EPS NY rev (1m)-0.29%
EPS NY rev (3m)9.42%
Revenue NQ rev (1m)0.27%
Revenue NQ rev (3m)1%
Revenue NY rev (1m)-3.38%
Revenue NY rev (3m)-6.04%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 23.72 | ||
| Fwd PE | 33.77 | ||
| P/S | 1.96 | ||
| P/FCF | 17.51 | ||
| P/OCF | 12.94 | ||
| P/B | 2.6 | ||
| P/tB | 2.6 | ||
| EV/EBITDA | 24.27 |
EPS(TTM)2.51
EY4.22%
EPS(NY)1.76
Fwd EY2.96%
FCF(TTM)3.4
FCFY5.71%
OCF(TTM)4.6
OCFY7.73%
SpS30.37
BVpS22.93
TBVpS22.93
PEG (NY)N/A
PEG (5Y)N/A
Graham Number35.99
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.52% | ||
| ROE | 6.69% | ||
| ROCE | 5.27% | ||
| ROIC | 4.82% | ||
| ROICexc | 8.98% | ||
| ROICexgc | 8.98% | ||
| OM | 4.16% | ||
| PM (TTM) | 5.05% | ||
| GM | 84.92% | ||
| FCFM | 11.2% |
ROA(3y)6.51%
ROA(5y)-0.53%
ROE(3y)7.56%
ROE(5y)-0.94%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.64%
GM growth 5Y0.15%
F-Score8
Asset Turnover1.09
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 276.46% | ||
| Cap/Sales | 3.95% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 270.95% | ||
| Profit Quality | 221.78% | ||
| Current Ratio | 5.29 | ||
| Quick Ratio | 4.01 | ||
| Altman-Z | 8.81 |
F-Score8
WACC10.02%
ROIC/WACC0.48
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)45.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%40.87%
EPS Next Y-29.76%
EPS Next 2Y1.11%
EPS Next 3Y11.77%
EPS Next 5Y14.46%
Revenue 1Y (TTM)13.6%
Revenue growth 3Y30.76%
Revenue growth 5Y51.2%
Sales Q2Q%12.25%
Revenue Next Year7.01%
Revenue Next 2Y8.03%
Revenue Next 3Y9.22%
Revenue Next 5Y10.27%
EBIT growth 1Y172.13%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year694.28%
EBIT Next 3Y129.9%
EBIT Next 5Y70.54%
FCF growth 1Y158.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y70.68%
OCF growth 3YN/A
OCF growth 5YN/A
INSPIRE MEDICAL SYSTEMS INC / INSP FAQ
What is the ChartMill fundamental rating of INSPIRE MEDICAL SYSTEMS INC (INSP) stock?
ChartMill assigns a fundamental rating of 6 / 10 to INSP.
Can you provide the valuation status for INSPIRE MEDICAL SYSTEMS INC?
ChartMill assigns a valuation rating of 4 / 10 to INSPIRE MEDICAL SYSTEMS INC (INSP). This can be considered as Fairly Valued.
How profitable is INSPIRE MEDICAL SYSTEMS INC (INSP) stock?
INSPIRE MEDICAL SYSTEMS INC (INSP) has a profitability rating of 5 / 10.
What are the PE and PB ratios of INSPIRE MEDICAL SYSTEMS INC (INSP) stock?
The Price/Earnings (PE) ratio for INSPIRE MEDICAL SYSTEMS INC (INSP) is 23.72 and the Price/Book (PB) ratio is 2.6.
What is the financial health of INSPIRE MEDICAL SYSTEMS INC (INSP) stock?
The financial health rating of INSPIRE MEDICAL SYSTEMS INC (INSP) is 9 / 10.